Physician profile
Mark E English
NPI 1699706929
$690.08
in general payments reported to CMS, 2019-2025
15 companies · $79.37 in 2025
The $79.37 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2021: $93.76 · 2022: $149 · 2023: $77.20 · 2024: $135 · 2025: $79.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $291.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braeburn INC. | $147.62 | 2024-2025 | Brixadi |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.00 | 2019 | |
| Novo Nordisk INC | $76.08 | 2019-2021 | |
| Abbvie INC. | $66.66 | 2021-2023 | |
| Indivior INC. | $62.74 | 2022-2024 | Sublocade |
| Novartis Pharmaceuticals Corporation | $51.83 | 2021-2022 | |
| Exeltis, USA INC. | $47.62 | 2022-2023 | Slynd |
| Astrazeneca Pharmaceuticals Lp | $31.99 | 2022 | |
| Xeris Pharmaceuticals, INC. | $17.67 | 2024 | Gvoke Hypopen |
| Exact Sciences Corporation | $16.34 | 2023 | Cologuard Collection Kit |
| Lilly USA, LLC | $16.09 | 2022 | |
| Pfizer INC. | $15.97 | 2024 | |
| Medtronic, INC. | $13.74 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.25 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark English listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.